Please assess the completion status of the following clinical trial:

Trial Title: Trial of NovoSeven® in Haemophilia - Joint Bleeds

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of hemophilia A or B with inhibitors to factor VIII or IX, respectively

- Gender: MALE
- Minimum Age: None
- Maximum Age: 20 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).